Cancer Care Ontario and ASCO Clinical Practice Guideline: Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer

March 15, 2017 – As reported in the Journal of Clinical Oncology by Dhesy-Thind, of Juravinski Cancer Centre, Hamilton Health Sciences, and colleagues, Cancer Care Ontario and ASCO have issued a clinical practice guideline on the use of adjuvant bisphosphonates and other bone-modifying agents in breast cancer. The two organizations convened a working group and expert panel to develop evidence-based recommendations based on a systematic … (leggi tutto)